iRadimed

IRMD75

High Quality

$49.50arrow_drop_up2.12%$1.03

High Quality

IRMD75

$49.50

arrow_drop_up2.12%$1.03

High Quality

Performance History

Key Stats
Open	$48.42
Prev. Close	$47.88
EPS	1.46

Next Earnings Date	Dec 2, 2024

	LOW	HIGH
Day Range	47.89	49.51
52 Week Range	36.12	50.93

Ratios







EPS	1.46

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About iRadimed (IRMD)

iRadimed Corp (IRMD) is a medical device company that specializes in the development, manufacturing, and marketing of magnetic resonance imaging (MRI) compatible products. The company's flagship product is the MRidium MRI infusion system, which is designed to safely deliver IV fluids and medications to patients undergoing MRI procedures. This innovative system eliminates the need for traditional infusion pumps, which can cause image artifacts and interfere with the quality of MRI scans. With its proprietary technology, iRadimed Corp has established itself as a leader in the MRI-compatible infusion pump market.

The stock price history of iRadimed Corp (IRMD) has shown steady growth over the years. From its initial public offering in 2006, the stock has consistently performed well, reflecting the company's strong financial performance and market position. Investors have been attracted to iRadimed Corp due to its unique product offering and the growing demand for MRI-compatible medical devices. The company's stock price has also benefited from positive news and advancements in the field of MRI technology.

Websitecall_made

Sector: Healthcare
Industry: Medical Devices
CEO: Mr. Roger E. Susi
Headquarters: Winter Springs
Employees: 123
Exchange: NASDAQ

Keep an eye on iRadimed

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is iRadimed's (IRMD) price per share?

The current price per share for iRadimed (IRMD) is $49.5. The stock has seen a price change of $1.03 recently, indicating a 2.13% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for iRadimed (IRMD)?

For iRadimed (IRMD), the 52-week high is $50.93, which is 2.89% from the current price. The 52-week low is $36.12, the current price is 37.04% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is iRadimed (IRMD) a growth stock?

iRadimed (IRMD) has shown an average price growth of 0.41% over the past three years. It has received a score of 81 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying iRadimed as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is iRadimed (IRMD) stock price performance year to date (YTD)?

As of the latest data, iRadimed (IRMD) has a year-to-date price change of 4.67%. Over the past month, the stock has experienced a price change of 9.68%. Over the last three months, the change has been 15.01%. Over the past six months, the figure is 11.81%. Looking at a longer horizon, the five-year price change stands at 114.38%.

help

Is iRadimed (IRMD) a profitable company?

iRadimed (IRMD) has a net income of $17.19M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 76.5% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 31.39% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $65.56M, with a revenue growth rate of 23%, providing insight into the company's sales performance and growth. The gross profit is $50.16M. Operating income is noted at $20.04M. Furthermore, the EBITDA is $22.26M.

help

What is the market capitalization of iRadimed (IRMD)?

iRadimed (IRMD) has a market capitalization of $614.11M. The average daily trading volume is 43.78K, indicating the stock's liquidity and investor engagement.